SK Biopharmaceuticals Partially Resolves Patent Lawsuit over Epilepsy drug... Settles with One Party

연합뉴스-Yonhap News Agency

Lean Right

Factuality

Ownership

(Seoul = Yonhap News) Reporter Park Sang-hyun = SK Biopharmaceuticals [326030] in a U.S. patent lawsuit regarding the new epilepsy drug 'Cenobamate' (U.S. product name Xcopri)...

조선일보

Lean Right

Factuality

Ownership

SK BioPharm has reached an agreement with a generic (generic) developer in a US patent lawsuit for “senobamate” (US product name Excopry), a treatment for epilepsy. SK BioPharm announced on the 19th that it has reached an agreement with Indian generic company MSN Laboratories in an ongoing patent lawsuit related to XCOPRY in the US Federal Court of Delaware. The specific terms of the agreement were not disclosed. This is a case surrounding a sub…